Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02102828 · ClinicalTrials.gov registry record · NA

Multimodal DVT Protocol in Tourniquet-less Total Knee Arthroplasty

A NA study of Deep Vein Thrombosis, sponsored by TriHealth.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT02102828: Completed NA study of Deep Vein Thrombosis, sponsored by TriHealth.

NCT02102828 is a NA study of Deep Vein Thrombosis that has completed, run by TriHealth. The registered enrollment target is 100 participants, below the 7,927-participant average among 24 other Deep Vein Thrombosis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02102828, a NA study of Deep Vein Thrombosis, has completed, sponsored by TriHealth.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The Cothera VPulse(tm) mechanical compression device (MCD) combines rapid intermittent sequential compression with cold therapy and is designed for single patient use in the home. Additionally, it can track patient compliance. This study will examine if there is a difference in deep vein thrombosis (DVT) occurrence over 3 weeks after tourniquet-less total knee arthroplasty (TKA) and multimodal prophylaxis with or without extended MCD use in a cooling device/MCD system.

Primary Outcome

DVT Occurence measured by physical assessment and duplex ultrasound images for DVT detection

Conditions Studied

Interventions

  • DEVICE extended compression
  • OTHER Aspirin

Study Locations (1)

Ohio

  • Good Samaritan Hosptial - Cincinnati

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2014-03
Est. Completion 2015-03
Phase NA
TriHealth

81 total trials

What the finished NCT02102828 record still lists

NCT02102828 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 7,927-participant average among 24 other Deep Vein Thrombosis trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Deep Vein Thrombosis appearing as the primary indexed condition, and to 2 interventions - of which extended compression is the first listed.

NCT02102828 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT02102828 about?

NCT02102828 is a clinical study titled "Multimodal DVT Protocol in Tourniquet-less Total Knee Arthroplasty". The Cothera VPulse(tm) mechanical compression device (MCD) combines rapid intermittent sequential compression with cold therapy and is designed for single patient use in the home. Additionally, it can track patient compliance. This study will examine if there is a difference in deep vein thrombosis ...

What is the current status of trial NCT02102828?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2014-03. Estimated completion is 2015-03.

What conditions does trial NCT02102828 study?

This clinical trial studies the following conditions: Deep Vein Thrombosis.

What interventions are being tested in trial NCT02102828?

The interventions under investigation include: extended compression (DEVICE), Aspirin (OTHER).

Who is sponsoring clinical trial NCT02102828?

This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02102828 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Deep Vein Thrombosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02102828's enrollment target sits among peer trials

100 17th of 24 higher than 8 of 24 other Deep Vein Thrombosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Deep Vein Thrombosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02102828, the US trial registry maintained by the National Library of Medicine. NCT02102828 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.